The effects of garlic supplementation on oxidative stress markers: A systematic review and meta-analysis of randomized controlled trials.


Journal

Complementary therapies in medicine
ISSN: 1873-6963
Titre abrégé: Complement Ther Med
Pays: Scotland
ID NLM: 9308777

Informations de publication

Date de publication:
May 2020
Historique:
received: 15 12 2019
revised: 23 02 2020
accepted: 16 03 2020
entrez: 24 5 2020
pubmed: 24 5 2020
medline: 20 11 2020
Statut: ppublish

Résumé

Recent studies have found that garlic supplementation can improve antioxidant status, however, there is no definitive consensus on this context. The present systematic review and meta-analysis aimed to investigate the effect of garlic supplementation on oxidative stress markers. We searched titles, abstracts, and keywords of relevant articles indexed in PubMed, ISI Web of Science, Scopus, and Google Scholar databases up to November 2019 to identify eligible RCT studies. To compare the effects of garlic with placebo, weighted mean difference (WMD) with 95 % confidence intervals (CI) were pooled based on the random-effects model. Quality assessment was performed using a Cochrane risk of bias assessment tool. Overall, 7 randomized controlled trials (RCTs) with 317 participants were included in this meta-analysis. Based on the Cochrane Collaboration Risk of Bias tool, five studies were considered as good quality and two studies were fair. We found that garlic supplementation significantly increased total antioxidant capacity (TAC) (WMD =11.03 mmol/L; 95 % CI: 4.78, 17.28 mmol/L; P < 0.001) and decreased malondialdehyde (MDA) levels (WMD = -1.88 mmol/L; 95 % CI: -3.30, -0.46 mmol/L; P = 0.01) compared with the control group. In summary, the current meta-analysis indicated that garlic supplementation might improve oxidative stress markers. However, these findings are incomplete due to the paucity of studies, and further well-designed clinical trials are needed in this field to confirm the effect of garlic supplement on oxidative stress markers.

Identifiants

pubmed: 32444050
pii: S0965-2299(19)31968-5
doi: 10.1016/j.ctim.2020.102385
pii:
doi:

Substances chimiques

Antioxidants 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102385

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Seyedeh Parisa Moosavian (SP)

Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.

Arman Arab (A)

Department of Community Nutrition, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Zamzam Paknahad (Z)

Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: paknahad@hlth.mui.ac.ir.

Sajjad Moradi (S)

Halal Research Center of IRI, FDA, Tehran, Iran; Nutritional Sciences Department, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH